Suppr超能文献

人系膜细胞中C型利钠肽受体的特性研究

Characterization of C-type natriuretic peptide receptors in human mesangial cells.

作者信息

Zhao J, Ardaillou N, Lu C Y, Placier S, Pham P, Badre L, Cambar J, Ardaillou R

机构信息

INSERM 64, Hôpital Tenon, Paris, France.

出版信息

Kidney Int. 1994 Sep;46(3):717-25. doi: 10.1038/ki.1994.326.

Abstract

Our aim was to examine whether the human glomerulus was a target for C-type natriuretic peptide (CNP) and how A, B and C receptors of natriuretic peptides (ANPR-A, ANPR-B, ANPR-C) were distributed in glomerular mesangial and epithelial cells. CNP stimulated cyclic GMP production in cultured human mesangial and epithelial cells with similar threshold concentrations (1 nM) and maximum effects (basal value x 30 at 1 microM). In contrast, atrial natriuretic peptide (ANP) was only stimulatory in epithelial cells. [125I] CNP bound specifically to mesangial cells with a Kd of 0.47 nM and Bmax of 42 fmol/mg. Equilibrium of binding was obtained after four to five hours at +4 degrees C and nonspecific binding represented 10 to 20% of total binding. HS142-1 (100 micrograms/ml), a specific inhibitor of ANPR-A and ANPR-B, suppressed 90% of CNP-dependent cyclic GMP production whereas it had little effect on [125I]-CNP binding, suggesting that C receptors were largely predominant in mesangial cells. No biological effect of CNP on mesangial cells, including change in basal or angiotensin II-induced contractility and inhibition of basal or serum-dependent proliferation, could be demonstrated. Similar results were obtained with 8-bromo-cyclic GMP and sodium nitroprusside. Intraglomerular localization of ANPR-A, ANPR-B and ANPR-C mRNA was studied using reverse transcriptase-polymerase chain reaction with amplification of their corresponding cDNA by different primers. Amplification products were identified on gel electrophoresis by their predicted sizes and sequencing. ANPR-A, ANPR-B and ANPR-C mRNA were present in epithelial cells whereas only ANPR-B and ANPR-C mRNA were detected in mesangial cells.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们的目的是研究人类肾小球是否为C型利钠肽(CNP)的作用靶点,以及利钠肽的A、B和C受体(ANPR-A、ANPR-B、ANPR-C)如何在肾小球系膜细胞和上皮细胞中分布。CNP在培养的人类系膜细胞和上皮细胞中刺激环磷酸鸟苷(cGMP)生成,其阈值浓度(1 nM)和最大效应(1 microM时为基础值的30倍)相似。相比之下,心房利钠肽(ANP)仅对上皮细胞有刺激作用。[125I]CNP以0.47 nM的解离常数(Kd)和42 fmol/mg的最大结合容量(Bmax)特异性结合系膜细胞。在+4℃下4至5小时后达到结合平衡,非特异性结合占总结合的10%至20%。HS142-1(100微克/毫升),一种ANPR-A和ANPR-B的特异性抑制剂,抑制了90%的CNP依赖性cGMP生成,而对[125I]-CNP结合影响很小,这表明C受体在系膜细胞中占主导地位。未发现CNP对系膜细胞有生物学效应,包括基础或血管紧张素II诱导的收缩性变化以及基础或血清依赖性增殖的抑制。8-溴环磷酸鸟苷和硝普钠也得到了类似结果。使用逆转录聚合酶链反应,通过不同引物扩增其相应的互补DNA(cDNA),研究了ANPR-A、ANPR-B和ANPR-C mRNA在肾小球内的定位。扩增产物通过其预测大小在凝胶电泳上进行鉴定并测序。ANPR-A、ANPR-B和ANPR-C mRNA存在于上皮细胞中,而在系膜细胞中仅检测到ANPR-B和ANPR-C mRNA。(摘要截短于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验